Featured Research

from universities, journals, and other organizations

Key enzyme that affects radiation response identified

Date:
January 27, 2011
Source:
University Health Network
Summary:
Cancer researchers have discovered that targeting an enzyme called uroporphyrinogen decarboxylase can sensitize diseased tissue to radiation and chemotherapy, which could mean fewer side effects for individuals with head and neck cancer.

Cancer researchers at Princess Margaret Hospital (PMH) have discovered that targeting an enzyme called uroporphyrinogen decarboxylase (UROD) can sensitize diseased tissue to radiation and chemotherapy, which could mean fewer side effects for individuals with head and neck cancer.

The findings, published online in Science Translational Medicine, are significant because they suggest that targeting UROD -- identified for the first time as a key player in human cancers -- can selectively boost the effects of radiotherapy and chemotherapy in head and neck tumors, while minimizing toxicity to normal tissues.

"Our analysis of patient biopsies revealed that UROD levels were significantly higher in tumor tissues versus normal tissues. Cancer patients with lower UROD levels prior to radiation treatment had improved clinical outcome, suggesting that UROD could potentially be used to predict patients' response to radiation therapy," says principal investigator, Dr. Fei-Fei Liu, Professor of Radiation Oncology at the University of Toronto and PMH, and Senior Scientist at the Ontario Cancer Institute and The Campbell Family Cancer Research Institute.

Lead author Dr. Emma Ito adds: "This means that lower doses of radiation and chemotherapeutic drugs could potentially be administered to patients without affecting treatment efficacy."

"Despite the advances over the last few decades, the toxic side effects associated with current therapies for head and neck cancer have caused disappointing outcomes in many patients," says Dr. Ito. Head and neck tumors are often found near critical structures, so destroying the diseased tissue is often a delicate challenge that can lead to life-threatening conditions.

"UROD is an enzyme involved in the production of a molecule called heme, which is vital to all body organs. Targeting UROD creates an opportunity to exploit the heme synthesis pathway, which disrupts the equilibrium of iron and free radical levels in cells which in turn kills cancer cells." says Dr. Liu.

The research was supported by the Canadian Institutes of Health Research, the Elia Chair in Head and Neck Cancer Research, the philanthropic support from the Wharton Family, Joe Finley, and Gordon Tozer, The Campbell Family Cancer Research Institute, the Ministry of Health and Long-Term Care, and The Princess Margaret Hospital Foundation.


Story Source:

The above story is based on materials provided by University Health Network. Note: Materials may be edited for content and length.


Journal Reference:

  1. E. Ito, S. Yue, E. H. Moriyama, A. B. Hui, I. Kim, W. Shi, N. M. Alajez, N. Bhogal, G. Li, A. Datti, A. D. Schimmer, B. C. Wilson, P. P. Liu, D. Durocher, B. G. Neel, B. O'Sullivan, B. Cummings, R. Bristow, J. Wrana, F.-F. Liu. Uroporphyrinogen Decarboxylase Is a Radiosensitizing Target for Head and Neck Cancer. Science Translational Medicine, 2011; 3 (67): 67ra7 DOI: 10.1126/scitranslmed.3001922

Cite This Page:

University Health Network. "Key enzyme that affects radiation response identified." ScienceDaily. ScienceDaily, 27 January 2011. <www.sciencedaily.com/releases/2011/01/110126144526.htm>.
University Health Network. (2011, January 27). Key enzyme that affects radiation response identified. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2011/01/110126144526.htm
University Health Network. "Key enzyme that affects radiation response identified." ScienceDaily. www.sciencedaily.com/releases/2011/01/110126144526.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins